ASTELLAS PHARMA UNSP.ADR (YPHA) — Working Capital to Net Assets Ratio
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Working Capital to Net Assets ratio of 9.2% as of March 2025. Working capital of €139.74 Billion (current assets of €1.20 Trillion minus current liabilities of €1.06 Trillion) is measured against net assets of €1.51 Trillion. A higher ratio indicates strong short-term liquidity financed by the equity base. See ASTELLAS PHARMA UNSP.ADR (YPHA) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ASTELLAS PHARMA UNSP.ADR Working Capital to Net Assets (2022–2025)
This chart shows how ASTELLAS PHARMA UNSP.ADR's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2025, the ratio stands at 9.2%, reflecting working capital of €139.74 Billion against net assets of €1.51 Trillion EUR. For the complete balance sheet picture, see ASTELLAS PHARMA UNSP.ADR balance sheet assets.
Annual Working Capital to Net Assets for ASTELLAS PHARMA UNSP.ADR (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are ASTELLAS PHARMA UNSP.ADR's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 9.2% | €139.74 Billion | €1.51 Trillion | €1.20 Trillion | €1.06 Trillion | ▲ +14.9 pp |
| 2024 | -5.7% | €-91.00 Billion | €1.60 Trillion | €1.19 Trillion | €1.29 Trillion | ▼ -27.2 pp |
| 2023 | 21.5% | €323.92 Billion | €1.51 Trillion | €1.05 Trillion | €726.03 Billion | ▲ +5.3 pp |
| 2022 | 16.2% | €235.94 Billion | €1.46 Trillion | €923.35 Billion | €687.41 Billion | — |